Hyperhomocysteinemia is a risk factor of middle cerebral artery stenosis

被引:73
作者
Hai Wei Huang [1 ]
Ming Hui Guo
Rui Jin Lin
Ya Li Chen
Qin Luo
Ying Zhang
Ka Sing Wong
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
关键词
homocysteine; transcranial doppler; hypertension; cerebral artery;
D O I
10.1007/s00415-006-0377-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpsose: Hyperhomocysteinemia (HHcy) is considered to be an independent risk factor for atherosclerosis. We aimed to determine the relation between Hcy and cerebral artery stenosis in a large Chinese population. Methods: We present data concerning 2,500 residents. Plasma was saved from 1,020 residents who were asymptomatic. Hcy concentration was measured by fluorescence ration biochemical assay kit, and middle cerebral artery (MCA) was assessed by Transcranial Doppler in these subjects. Results: Fifty-six residents with MCA stenosis were included in this study. The remained 964 residents without stenosis were control. Analysis of the data revealed that the plasma concentration of Hcy (18.33 +/- 5.34 mu mol/L), age (63.9 +/- 12.9) and systolic pressure (142.6 +/- 22.6 mmHg) in the stenotic group were increased (p < 0.0001) compared with the control group (Hcy12.95 +/- 4.57 mu mol/L, age 55.8 +/- 10.9, systolic pressure 126.3 +/- 20.3 mmHg). Based on logistic regression, 5 factors emerged as independent predictors of MCA stenosis: Hcy (OR = 1.16, 95%confidence interval 1.14-1.26), male (OR = 2.63, 95%CI 1.49-4.66), age (OR = 1.04, 95%CI 1.01-1.07), hypertension (OR = 9.16, 95%CI 4.57-18.35), diabetes mellitus (OR = 5.90, 95%CI 3.09-11.29). Conclusion: Hyperhomocysteinemia might be one of the risk factors for cerebral artery stenosis. It may play a role in atherosclerosis and thrombosis.
引用
收藏
页码:364 / 367
页数:4
相关论文
共 12 条
[1]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[2]   Blood levels off homocysteine and increased risks of cardiovascular disease -: Causal of casual? [J].
Christen, WG ;
Ajani, UA ;
Glynn, RJ ;
Hennekens, CH .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :422-434
[3]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[4]  
Fassbender K, 1999, LANCET, V353, P1586
[5]   Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease [J].
Hogervorst, E ;
Ribeiro, HM ;
Molyneux, A ;
Budge, M ;
Smith, D .
ARCHIVES OF NEUROLOGY, 2002, 59 (05) :787-793
[6]  
HUANG YN, 1997, CHINESE J NEUROL, V30, P98
[7]   Homocyst(e)ine, diet, and cardiovascular diseases - A statement for healthcare professionals from the Nutrition Committee, American Heart Association [J].
Malinow, MR ;
Bostom, AG ;
Krauss, RM .
CIRCULATION, 1999, 99 (01) :178-182
[8]  
Moller J, 2000, SCAND J CLIN LAB INV, V60, P491
[9]   Homocysteine in neuropsychiatric disorders of the elderly [J].
Reutens, S ;
Sachdev, P .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 17 (09) :859-864
[10]   Hyperhomocysteinemia and atherosclerotic vascular disease - Pathophysiology, screening, and treatment [J].
Stein, JH ;
McBride, PE .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (12) :1301-1306